Clinical trial

A Pilot Randomized Controlled Crossover Trial of the Effectiveness of Disposable Nitrous Oxide Canisters in Providing Improved Pain Control During Burn Dressing Changes.

Name
nitrousoxide
Description
Improvements in burn care have resulted in increased survival. Despite these improved outcomes one of the leading challenges of burn care remains providing adequate analgesia during routine wound care and dressing changes. The traditional use of narcotics is challenging as the therapeutic window between analgesia and suppression of breathing becomes narrow with the intense pain and high doses of narcotics needed for dressing changes.
Trial arms
Trial start
2019-10-01
Estimated PCD
2025-12-01
Trial end
2026-12-01
Status
Recruiting
Phase
Early phase I
Treatment
Nitrous Oxide Inhalant Product
Nitrous Oxide Inhalant Product
Arms:
Nitrous Oxide Inhalant Product
Placebo
Inactive comparator
Arms:
Placebo
Size
30
Primary endpoint
Burn Specific Pain Anxiety Scale
1 hour before dressing change
Burn Specific Pain Anxiety Scale
during dressing change
Burn Specific Pain Anxiety Scale
1 hour after dressing change
Visual Analogue Scale for pain
1 hour before dressing change
Visual Analogue Scale for pain
during dressing change
Visual Analogue Scale for pain
1 hour after dressing change
Visual Analogue Scale for anxiety
1 hour before dressing change
Visual Analogue Scale for anxiety
during dressing change
Visual Analogue Scale for anxiety
1 hour after dressing change
Eligibility criteria
Inclusion criteria * adult burn patients admitted to the Health Sciences Centre * total body surface area burned of 5-20% Exclusion criteria * admitted to intensive care unit * unable to participate in the measurement outcomes (sedated, cognitively impaired, unable to understand English or visually impaired) * medical condition that precludes using nitrous oxide (respiratory disease and significant cardiovascular disease 5). * pregnant * physically unable to hold the canister * \<90% SaO2 on room air * face burn * pre-injury narcotics (relative exclusion) * use of IV ketamine * pre-existing lung injury
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['EARLY_PHASE1'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'CROSSOVER', 'interventionModelDescription': 'Randomized to receive either active study article or inactive comparator then crossed over to other treatment arm on next dressing change.', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'DOUBLE', 'whoMasked': ['PARTICIPANT', 'OUTCOMES_ASSESSOR']}}, 'enrollmentInfo': {'count': 30, 'type': 'ESTIMATED'}}
Updated at
2023-11-29

1 organization

1 product

1 drug

3 indications

Indication
Burns
Indication
Pain
Indication
Acute